Lisa Wolf has been named Interim Chief Financial Officer (CFO) of Tivic Health® Systems, Inc., a health technology business that develops and commercialises bioelectronic medicine. Her position will take effect on October 1, 2024. Kimberly Bambach, who has been the company’s acting CFO since April 2023, will be replaced by Ms. Wolf. Ms. Bambach will stay on with Tivic to continue serving as an advisor on special projects and strategic deals.
Ms. Wolf offers thirty years of expertise leading financial teams in both public and commercial businesses across many industries. During her time working with Tivic, she has developed a thorough understanding of the company’s financial environment and has made a number of noteworthy accomplishments, such as streamlining the financial procedures. In addition, Ms. Wolf is the Vice President of Murdock Martell at the moment. She was previously employed by Arthur Andersen and Resonant, Inc.
The previous manager of Ms. Wolf, Ms. Bambach, will be involved in the business as an advisor, concentrating on special initiatives and strategic deals. Her sustained participation will guarantee a smooth transition and give Tivic access to her special transactional and integrational capabilities going forward.
